Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
about
Biomarkers for diagnosis of Wilson's diseaseCopper phenotype in Alzheimer's disease: dissecting the pathwayPhotoinitiated nitric oxide-releasing tertiary S-nitrosothiol-modified xerogels.Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.Stöber Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles.Glutamate-mediated primary somatosensory cortex excitability correlated with circulating copper and ceruloplasminElectroencephalographic Fractal Dimension in Healthy Ageing and Alzheimer's Disease.Usefulness of ferroxidase activity of ceruloplasmin in the diagnosis of Wilson's disease.Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's diseaseNitric oxide-releasing S-nitrosothiol-modified xerogels.Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?Genetics of Wilson's disease: a clinical perspective.Clinical considerations for an effective medical therapy in Wilson's disease.Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans.Copper:caeruloplasmin ratio.Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients.Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.Sensorimotor Cortex Reorganization in Alzheimer's Disease and Metal Dysfunction: A MEG Study.Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease.ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease.Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses.Caeruloplasmin oxidase activity: measurement in serum by use of o-dianisidine dihydrochloride on a microplate reader.An exploratory study of BDNF and oxidative stress marker alterations in subacute and chronic stroke patients affected by neuropathic pain.The effect of copper from water and food: changes of serum nonceruloplasmin copper and brain's amyloid-beta in mice.Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease.Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy.The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease.Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.Prognostic Value of Serum Copper for Post-Stroke Clinical Recovery: A Pilot Study.
P2860
Q26471573-D22759C9-C7BB-4FDB-BA6A-323A6B26B591Q28294380-E6DB35B8-F090-4E62-AA59-62D1E9513B10Q30505742-F01CAE96-0C49-40E6-A386-94BD6C2EC769Q34660301-561003A4-3BEC-40AC-8637-7E7F9E97DCBEQ34784911-8821FD01-A1EF-47AF-88DD-3127B1FAF3C5Q35582469-055D9756-BB7B-4944-A859-4126116D569AQ35922648-F4A0D35F-5D40-482D-A919-CF3163A1CCB2Q36263901-2287CF29-BD49-4FD7-B2B7-8D7AEF27A87DQ37080419-8B6FD638-FF37-474C-9275-0287DB5B0FFCQ37345886-7FA9C355-5413-470E-B276-16D8D3AC97E8Q37635602-39B664C8-6B95-4640-B05F-2D275C3BFC84Q38039981-BECE98C7-A07B-4BCA-A9F8-1E355DCDC9DCQ38206268-9E055F68-42CE-4BC6-BB15-B130E71BC2C5Q40032173-EA7F2B1F-2FD8-4F45-8E11-6B30DBEF9261Q40353660-190826EF-C1E1-4B67-BB8C-B7DB98BC4FFFQ41134452-B631485F-1FC0-4304-90A8-13AA9DAEC2F5Q41895354-4A153FA3-66F1-42EE-8283-B1F32A7EE00FQ42013144-D3982C56-D39D-4A7E-97FE-8D3425BEE87EQ42768023-19266AD3-86F3-4382-92E5-C741EA312C32Q42791835-3D2289A9-E66C-49C8-BDD2-2DCBFFBCFA70Q44239135-D1919371-6D7A-41DB-A1B0-C2C5041D0EE5Q45898364-F0AC0BEF-3978-49E7-BECA-5C9859EFC452Q46458603-C90C0EE1-EF4F-48A7-ABB9-86CEE6B2209BQ47982808-CC2487B1-7A9D-42D5-B8D5-4902543EA4B0Q47994138-C310FBB6-4407-4FAB-B379-3FAAB802EC48Q48579014-DB056228-4ACE-4C8D-A24E-76C12302D5EBQ51194001-D30F8FEE-64ED-4000-ADA8-910EA80E1F52Q51325096-C804C360-91BD-486F-915E-853567600CB9Q51392359-78082110-67CC-48B1-BF1B-E1396BB8EE9CQ51587028-1C3975E9-B1A3-43CA-8A6D-79001D31498AQ53485291-6F3F5A84-BB5B-4D3F-B522-205D6F8C8DCFQ55302828-3C013EAA-4499-44EA-BFA3-0366BFC55ABB
P2860
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
@ast
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
@en
type
label
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
@ast
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
@en
prefLabel
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
@ast
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
@en
P1476
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
@en
P2093
Clinical Investigations Standing Committee of the Association of Clinical Biochemists
J M Walshe
P304
P356
10.1258/000456303763046021
P577
2003-03-01T00:00:00Z